Showing results (141-150 of 232) with videos related to

Sort By:
Pageof 24
Blood Advances|September 8, 2018
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamideLaura K Schoch, Kenneth R Cooke, Nina D Wagner-Johnston, et al.
Blood|November 29, 2007
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host diseaseJohn E Levine, Sophie Paczesny, Shin Mineishi, et al.
Blood|January 31, 2012
Plasma biomarkers of lower gastrointestinal and liver acute GVHDAndrew C Harris, James L M Ferrara, Thomas M Braun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomesLawrence Chang, David Frame, Thomas Braun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2016
Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant DisordersOrly R Klein, Allen R Chen, Christopher Gamper, et al.
Transplantation and Cellular Therapy|March 1, 2026
Post-transplant Cyclophosphamide (PTCy) for HLA-Matched Hematopoietic Stem Cell Transplant (HCT) in Pediatric and Young Adult Patients with Hematologic MalignanciesMegan Murphy, Hua-Ling Tsai, Allen Chen, et al.
Pediatric Blood & Cancer|April 23, 2015
Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemiaRolla F Abu-Arja, Leah R Chernin, Ghada Abusin, et al.
The Journal of Clinical Investigation|June 24, 2008
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in micePavan Reddy, Yaping Sun, Tomomi Toubai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2017
Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived MalignancyRobbie G Majzner, Huzefa Mogri, Ravi Varadhan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2010
Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activationInes A Silva, Krystyna Olkiewicz, David Askew, et al.
Pageof 24